USA Trends and Developments
Trends and Developments Contributed by: David McIntosh, Matt Byron, Zoe Dettelbach, Paul Matheke and Toby Shao Ropes & Gray
Ropes & Gray is home to one of the world’s pre-em- inent life sciences groups, with a global platform for innovators at every stage of the development lifecy- cle. Its collaborative approach spanning more than 25 practice areas and touching all 16 offices (New York, Boston, Chicago, Los Angeles, San Francisco, Silicon Valley, Washington, D.C., London, Dublin, Mi- lan, Paris, Hong Kong, Seoul, Singapore, and Tokyo) offers one of the largest and most experienced in- dustry-specific teams, comprised of more than 300+
lawyers, subject matter experts and technical advi- sors, who deliver sophisticated transactional, regula- tory, IP, and litigation and enforcement strategies to position industry innovators and investors for suc- cess. The firm is sought after to lead clients in navi- gating the complex legal landscape in which the life sciences industry operates. It has recently success- fully represented clients such as AbbVie, Alnylam, Eli Lilly, Novavax, Novo Nordisk, Pfizer, and Sanofi.
Authors
David McIntosh advises a wide range of companies, investors, and institutions in the life sciences industry on strategic transactions involving intellectual property and technology, with particular focus on
Matt Byron is a leading transactional advisor with deep experience guiding public and private company clients through their most complex M&A transactions in numerous industries, including life sciences, healthcare,
strategic collaborations and licensing transactions, mergers and acquisitions, joint ventures, supply and distribution arrangements, and co-commercialisation and marketing agreements. Recognised by leading legal directories, including Chambers and Partners, and other publications as a leading practitioner in his field, David provides practical, commercial advice that leverages his over 25 years of experience representing key players in the life sciences industry.
technology and industrials. Matt regularly advises clients on both the buy-side and sell-side of M&A transactions, with market-leading expertise in alternative M&A structures, including asset sales and carve-outs, shareholder spin-out transactions, options to acquire or license, and hybrid licensing and M&A structures. Matt has led recent high-profile M&A transactions for Novo Nordisk, Johnson & Johnson, Gilgamesh Pharmaceuticals, Sanofi, Toast, Qorvo and EMCOR.
Zoe Dettelbach joined Ropes & Gray in 2024 and is an associate in the intellectual property transactions group in Boston. Zoe received her JD from Georgetown University Law Center. While in law school, Zoe
Paul Matheke joined the corporate department in Ropes & Gray’s Boston office in 2025. Paul earned his JD from the University of Illinois College of Law, graduating summa cum laude. While in law school, he
completed an internship at the National Science Foundation Office of Inspector General and interned throughout all three years of law school at a boutique regulatory and transactional law firm supporting the life sciences. Additionally, Zoe was a member of the Barristers’ Council Alternative Dispute Resolution team, during which time she and her co-counsel were awarded first place negotiation team at the Taft Transactional Law Invitational.
interned with AbbVie Inc.’s transactions team. Prior to law school, Paul earned a BS in Pharmaceutical Sciences and a Doctor of Pharmacy (PharmD) from The Ohio State University.
410 CHAMBERS.COM
Powered by FlippingBook